Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

BUY
$7.06 - $23.63 $7,060 - $23,630
1,000 Added 1.59%
64,000 $535,000
Q1 2022

May 03, 2022

SELL
$21.6 - $27.79 $302,400 - $389,060
-14,000 Reduced 18.18%
63,000 $1.44 Million
Q4 2021

Feb 09, 2022

BUY
$23.0 - $29.01 $207,000 - $261,090
9,000 Added 13.24%
77,000 $2.13 Million
Q3 2021

Nov 12, 2021

BUY
$25.04 - $30.06 $325,520 - $390,780
13,000 Added 23.64%
68,000 $1.89 Million
Q2 2021

Aug 11, 2021

BUY
$27.43 - $32.7 $109,720 - $130,800
4,000 Added 7.84%
55,000 $1.61 Million
Q1 2021

May 21, 2021

SELL
$21.37 - $34.38 $33.5 Million - $53.9 Million
-1,567,740 Reduced 96.85%
51,000 $1.62 Million
Q1 2021

May 17, 2021

BUY
$21.37 - $34.38 $33.3 Million - $53.6 Million
1,557,740 Added 2553.67%
1,618,740 $51 Million
Q3 2020

Nov 12, 2020

BUY
$14.88 - $20.13 $44,640 - $60,390
3,000 Added 5.17%
61,000 $948 Million
Q2 2020

Aug 13, 2020

BUY
$13.31 - $20.51 $177,023 - $272,783
13,300 Added 29.75%
58,000 $1.06 Billion
Q1 2020

May 15, 2020

BUY
$12.98 - $30.25 $64,900 - $151,250
5,000 Added 12.59%
44,700 $693 Million
Q4 2019

Feb 11, 2020

SELL
$18.89 - $31.89 $151,120 - $255,120
-8,000 Reduced 16.77%
39,700 $1.19 Billion
Q3 2019

Nov 12, 2019

BUY
$20.88 - $25.66 $20,880 - $25,660
1,000 Added 2.14%
47,700 $1.04 Billion
Q2 2019

Aug 15, 2019

SELL
$20.52 - $26.45 $164,160 - $211,600
-8,000 Reduced 14.63%
46,700 $1.18 Billion
Q1 2019

May 10, 2019

SELL
$20.23 - $26.29 $778,855 - $1.01 Million
-38,500 Reduced 41.31%
54,700 $1.35 Billion
Q4 2018

Feb 14, 2019

BUY
$17.64 - $28.32 $52,920 - $84,960
3,000 Added 3.33%
93,200 $1.72 Billion
Q3 2018

Nov 08, 2018

SELL
$20.64 - $25.67 $41,280 - $51,340
-2,000 Reduced 2.17%
90,200 $2.32 Billion
Q2 2018

Aug 01, 2018

BUY
$15.07 - $26.86 $1.39 Million - $2.48 Million
92,200 New
92,200 $2.14 Billion

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Factorial Partners, LLC Portfolio

Follow Factorial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Factorial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Factorial Partners, LLC with notifications on news.